Related Experiment Video
Updated: Mar 20, 2026
07:22
Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
Published on: August 19, 2021
3.5K
[Possibilities of bacteriophage therapy]
Duodecim; Laaketieteellinen Aikakauskirja
|June 2, 2016
Summary
Bacteriophages (phages), viruses that kill bacteria, offer a promising alternative to antibiotics for treating infections, especially those caused by multi-resistant bacteria. Clinical trials for phage therapy are set to begin in Finland.
Area of Science:
- Microbiology
- Virology
- Infectious Diseases
Context:
- Rising antibiotic resistance poses a significant global health threat.
- Bacterial pathogens are increasingly developing resistance to conventional antibiotic treatments.
- There is an urgent need for novel therapeutic strategies to combat bacterial infections.
Purpose:
- To explore the potential of bacteriophage (phage) therapy as an alternative or complementary treatment to antibiotics.
- To investigate the efficacy of phages against multi-resistant bacterial pathogens.
- To initiate clinical trials for phage therapy in Finland.
Summary:
- Bacteriophages are viruses that specifically infect and kill bacteria.
- Phage therapy utilizes these viruses to treat bacterial infections, including those caused by antibiotic-resistant strains.
- Phages exhibit narrow host specificity, targeting only specific bacteria without harming beneficial microbiota, unlike broad-spectrum antibiotics.
Impact:
- Phage therapy presents a viable alternative to antibiotics, particularly for multi-drug resistant infections.
- The specificity of phages offers a safer treatment option by preserving the host's normal microbiota.
- Upcoming clinical trials in Finland will provide crucial data on the safety and efficacy of phage therapy in humans.
More Related Videos
Related Concept Videos
01:30Lytic Cycle of Bacteriophages
79.7K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
79.7K
01:26DNA Bacteriophages
1.3K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.3K
00:43Lysogenic Cycle of Bacteriophages
69.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
69.3K
01:16Viral Replication: Lysogenic Cycle
2.2K
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
2.2K
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
01:20Viral Replication: Lytic Cycle
2.4K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
2.4K